Correlation Between Zenas BioPharma, and Zivo Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zenas BioPharma, and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenas BioPharma, and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenas BioPharma, Common and Zivo Bioscience Warrants, you can compare the effects of market volatilities on Zenas BioPharma, and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenas BioPharma, with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenas BioPharma, and Zivo Bioscience.

Diversification Opportunities for Zenas BioPharma, and Zivo Bioscience

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Zenas and Zivo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zenas BioPharma, Common and Zivo Bioscience Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience Warrants and Zenas BioPharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenas BioPharma, Common are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience Warrants has no effect on the direction of Zenas BioPharma, i.e., Zenas BioPharma, and Zivo Bioscience go up and down completely randomly.

Pair Corralation between Zenas BioPharma, and Zivo Bioscience

If you would invest  671.00  in Zenas BioPharma, Common on November 28, 2024 and sell it today you would earn a total of  31.00  from holding Zenas BioPharma, Common or generate 4.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Zenas BioPharma, Common  vs.  Zivo Bioscience Warrants

 Performance 
       Timeline  
Zenas BioPharma, Common 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zenas BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Etf's forward indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors.
Zivo Bioscience Warrants 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zivo Bioscience Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Zivo Bioscience is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Zenas BioPharma, and Zivo Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zenas BioPharma, and Zivo Bioscience

The main advantage of trading using opposite Zenas BioPharma, and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenas BioPharma, position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.
The idea behind Zenas BioPharma, Common and Zivo Bioscience Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
CEOs Directory
Screen CEOs from public companies around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format